ML20054G376
| ML20054G376 | |
| Person / Time | |
|---|---|
| Issue date: | 05/06/1976 |
| From: | Bowyer J NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS) |
| To: | Vincent N ST. VINCENTS MEDICAL CENTER, BRIDGEPORT, CT |
| Shared Package | |
| ML20054G353 | List: |
| References | |
| FRN-47FR15801, RULE-PR-50 NUDOCS 8206210500 | |
| Download: ML20054G376 (1) | |
Text
_
g#""*%
UNITED STATEE y
NUCLEAR REGULATORY COMMISSION P
o WASHINGTON, D. C. 20856 Ch
/
\\0/b 7
%..v<f j (%
MAY f.
1376 FCMS:RLB JEB (71607) 1 St. Vircint's Hospital ATTN:
Nonnan R. Vincent, M.D.
Department of Nuclear Medicine 2820 Main Street Bridgeport, Connecticut 06606 Gentlemen:
(
In support of your application to use Tc99M sulphur colloid to assess the intracavity distribution of P-32 chromic phosphate and Tc99M pyrophosphate for myocardial -imagery you should submit evidence that your procurement, preparation and use of this material will be in accordance with the Federal Food, Drug and Cosmetic Act O
and the Public Health Service Act, or that they are exempt from these acts.
We will continue our review of your application upon receipt of this information.
Please refer to Control No. 71607 in your reply.
Sincerely, J
o er Radioisotopes Licensing Branch Division of Fuel Cycle and Material Safety y 6:t J 6
kj6gosoo820611 50 A7fR15R01 Pnn